HARNAL Side Effects

6347377-8 | Pustular Psoriasis
on Sep 08, 2009 Male patient from GERMANY , 66 years of age, was diagnosed with benign prostatic hyperplasia, gastric ulcer, myocardial infarction, angina pectoris, pustular psoriasis, gout (What is gout?), hypercholesterolaemia and was treated with Harnal (View Usage). Patient experienced the following unwanted or unexpected effects: pustular psoriasis. Harnal dosage: . During the same period patient was treated with PROMAC (View Promac Review and Promac Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), GASTER D (View Gaster D Review and Gaster D Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), NEORAL (View Neoral Review and Neoral Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), LOCHOL (View Lochol Review and Lochol Label ). Patient was hospitalized.

6339538-9 | Pustular Psoriasis
Patient was taking Harnal (View Usage). Patient had the following side effects: pustular psoriasis on Aug 21, 2009 from GERMANY Additional patient health information: Male patient , 66 years of age, was diagnosed with benign prostatic hyperplasia, gastric ulcer, myocardial infarction, angina pectoris, pustular psoriasis, gout (What is gout?), hypercholesterolaemia and. Harnal dosage: . During the same period patient was treated with PROMAC (View Promac Review and Promac Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), GASTER D (View Gaster D Review and Gaster D Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), NEORAL (View Neoral Review and Neoral Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), LOCHOL (View Lochol Review and Lochol Label ). Patient was hospitalized.

6167864-5 | Arrhythmia, Nasal Congestion
Adverse event was reported on Apr 21, 2009 by a Male patient taking Harnal (View Usage) (Dosage: ) was diagnosed with nephrolithiasis and. Location: , 21 years of age, After Harnal was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), nasal congestion. During the same period patient was treated with CEFIXIME CHEWABLE (View Cefixime Chewable Review and Cefixime Chewable Label ). Patient was hospitalized.

6164540-X | Ascites, Hepatic Neoplasm Malignant, Hepatitis Fulminant
on Mar 24, 2009 Male patient from , weighting 132.3 lb, was diagnosed with benign prostatic hyperplasia, insomnia, depression (What is depression?) and was treated with Harnal (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, hepatic neoplasm malignant, hepatitis fulminant. Harnal dosage: .2mg. During the same period patient was treated with LENDORMIN D TABLETS (.5mg) (View Lendormin D Tablets Review and Lendormin D Tablets Label ), SOLANAX (2.4mg) (View Solanax Review and Solanax Label ), TOLEDOMIN (200mg) (View Toledomin Review and Toledomin Label ), TETRAMIDE (60mg) (View Tetramide Review and Tetramide Label ), MYSLEE (5mg) (View Myslee Review and Myslee Label ). Patient was hospitalized.


6135821-0 | Ascites, Hepatic Neoplasm Malignant, Hepatitis Fulminant
on Mar 24, 2009 Male patient from , weighting 132.3 lb, was diagnosed with benign prostatic hyperplasia, insomnia, depression (What is depression?) and was treated with Harnal (View Usage). Patient had the following side effects: ascites, hepatic neoplasm malignant, hepatitis fulminant. Harnal dosage: .2mg. During the same period patient was treated with LENDORMIN D TABLETS (.5mg) (View Lendormin D Tablets Review and Lendormin D Tablets Label ), SOLANAX (2.4mg) (View Solanax Review and Solanax Label ), TOLEDOMIN (200mg) (View Toledomin Review and Toledomin Label ), TETRAMIDE (60mg) (View Tetramide Review and Tetramide Label ), MYSLEE (5mg) (View Myslee Review and Myslee Label ). Patient was hospitalized.

6124970-9 | Ascites, Hepatic Neoplasm Malignant, Hepatitis Fulminant
Patient was taking Harnal (View Usage). After Harnal was administered, patient had the following side effects: ascites, hepatic neoplasm malignant, hepatitis fulminant on Mar 17, 2009 from Additional patient health information: Male patient , weighting 132.3 lb, was diagnosed with benign prostatic hyperplasia, insomnia, depression (What is depression?) and. Harnal dosage: .2mg. During the same period patient was treated with LENDORMIN D TABLETS (.5mg) (View Lendormin D Tablets Review and Lendormin D Tablets Label ), SOLANAX (2.4mg) (View Solanax Review and Solanax Label ), TOLEDOMIN (200mg) (View Toledomin Review and Toledomin Label ), TETRAMIDE (60mg) (View Tetramide Review and Tetramide Label ), MYSLEE (5mg) (View Myslee Review and Myslee Label ). Patient was hospitalized.

6083018-5 | Interstitial Lung Disease, Polymyositis
Adverse event was reported on Feb 12, 2009 by a Male patient taking Harnal (View Usage) (Dosage: .2mg) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: , 68 years of age, weighting 108.0 lb, Patient experienced the following unwanted or unexpected effects: interstitial lung disease, polymyositis. During the same period patient was treated with BICALUTAMIDE (View Bicalutamide Review and Bicalutamide Label ), LEUPROLIDE ACETATE (View Leuprolide Acetate Review and Leuprolide Acetate Label ).

6069526-1 | Interstitial Lung Disease, Polymyositis
on Feb 04, 2009 Male patient from , 68 years of age, weighting 108.0 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Harnal (View Usage). Patient had the following side effects: interstitial lung disease, polymyositis. Harnal dosage: .2mg. During the same period patient was treated with BICALUTAMIDE (View Bicalutamide Review and Bicalutamide Label ), LEUPROLIDE ACETATE (View Leuprolide Acetate Review and Leuprolide Acetate Label ).

6061759-3 | Interstitial Lung Disease
on Jan 27, 2009 Male patient from , 68 years of age, weighting 108.0 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Harnal (View Usage). After Harnal was administered, patient had the following side effects: interstitial lung disease. Harnal dosage: . During the same period patient was treated with BICALUTAMIDE (View Bicalutamide Review and Bicalutamide Label ), LEUPROLIDE ACETATE (View Leuprolide Acetate Review and Leuprolide Acetate Label ).

5947114-2 | Ascites, Hepatic Neoplasm Malignant, Hepatitis Fulminant
Patient was taking Harnal (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, hepatic neoplasm malignant, hepatitis fulminant on Nov 05, 2008 from Additional patient health information: Male patient , weighting 132.3 lb, was diagnosed with benign prostatic hyperplasia, insomnia and. Harnal dosage: .2mg. During the same period patient was treated with LENDORMIN D TABLETS (.5mg) (View Lendormin D Tablets Review and Lendormin D Tablets Label ), SOLANAX (2.4mg) (View Solanax Review and Solanax Label ), TOLEDOMIN (200mg) (View Toledomin Review and Toledomin Label ), TETRAMIDE (60mg) (View Tetramide Review and Tetramide Label ), MYSLEE (5mg) (View Myslee Review and Myslee Label ), DEPAS (1mg) (View Depas Review and Depas Label ), ZOLOFT (100mg) (View Zoloft Review and Zoloft Label ), ZEFIX (View Zefix Review and Zefix Label ). Patient was hospitalized.

5924274-0 | Ascites, Hepatic Neoplasm Malignant, Hepatitis Fulminant
Adverse event was reported on Oct 15, 2008 by a Male patient taking Harnal (View Usage) (Dosage: .2mg) was diagnosed with benign prostatic hyperplasia, insomnia and. Location: , weighting 132.7 lb, Patient had the following side effects: ascites, hepatic neoplasm malignant, hepatitis fulminant. During the same period patient was treated with LENDORMIN D TABLETS (.5mg) (View Lendormin D Tablets Review and Lendormin D Tablets Label ), SOLANAX (2.4mg) (View Solanax Review and Solanax Label ), TOLEDOMIN (200mg) (View Toledomin Review and Toledomin Label ), TETRAMIDE (60mg) (View Tetramide Review and Tetramide Label ), MYSLEE (5mg) (View Myslee Review and Myslee Label ), DEPAS (1mg) (View Depas Review and Depas Label ), ZOLOFT (100mg) (View Zoloft Review and Zoloft Label ), ZEFIX (View Zefix Review and Zefix Label ). Patient was hospitalized.

5858706-3 | Atrioventricular Block Second Degree, Gynaecomastia
on Aug 19, 2008 Male patient from JAPAN , 84 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Harnal (View Usage). After Harnal was administered, patient had the following side effects: atrioventricular block second degree, gynaecomastia. Harnal dosage: . During the same period patient was treated with TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), MYSLEE (View Myslee Review and Myslee Label ), KETAS (View Ketas Review and Ketas Label ), DAREN (View Daren Review and Daren Label ).

5840834-X | Atrioventricular Block Second Degree, Gynaecomastia
on Aug 06, 2008 Male patient from JAPAN , 84 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Harnal (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block second degree, gynaecomastia. Harnal dosage: . During the same period patient was treated with TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), MYSLEE (View Myslee Review and Myslee Label ), KETAS (View Ketas Review and Ketas Label ), DAREN (View Daren Review and Daren Label ).

5671546-3 | Cataract Nuclear, Floppy Iris Syndrome
Patient was taking Harnal (View Usage). Patient had the following side effects: cataract nuclear, floppy iris syndrome on Mar 10, 2008 from JAPAN Additional patient health information: Male patient , weighting 116.8 lb, was diagnosed with benign prostatic hyperplasia, tremor and. Harnal dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), GLIMICRON (View Glimicron Review and Glimicron Label ), BASEN (View Basen Review and Basen Label ), JUVELA NICOTINATE (View Juvela Nicotinate Review and Juvela Nicotinate Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), FLUMETHOLON (View Flumetholon Review and Flumetholon Label ).

5665086-5 | Cataract Nuclear, Floppy Iris Syndrome
Adverse event was reported on Mar 10, 2008 by a Male patient taking Harnal (View Usage) (Dosage: ) was diagnosed with benign prostatic hyperplasia, tremor and. Location: JAPAN , weighting 116.8 lb, After Harnal was administered, patient had the following side effects: cataract nuclear, floppy iris syndrome. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), GLIMICRON (View Glimicron Review and Glimicron Label ), BASEN (View Basen Review and Basen Label ), JUVELA NICOTINATE (View Juvela Nicotinate Review and Juvela Nicotinate Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), FLUMETHOLON (View Flumetholon Review and Flumetholon Label ).

5575392-0 | Biliary Tract Disorder, Liver Disorder
on Dec 20, 2007 Male patient from JAPAN , weighting 145.5 lb, was diagnosed with benign prostatic hyperplasia, cerebral infarction, hypertension, constipation (What is constipation?), diabetes mellitus and was treated with Harnal (View Usage). Patient experienced the following unwanted or unexpected effects: biliary tract disorder, liver disorder. Harnal dosage: . During the same period patient was treated with BUFFERIN (View Bufferin Review and Bufferin Label ), RENIVEZE (View Reniveze Review and Reniveze Label ), OZAGREL SODIUM (View Ozagrel Sodium Review and Ozagrel Sodium Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ), CETILO (RHUBARB/SENNA) (View Cetilo (rhubarb/senna) Review and Cetilo (rhubarb/senna) Label ), INSULIN INJECTION, BIPHASIC (View Insulin Injection, Biphasic Review and Insulin Injection, Biphasic Label ). Patient was hospitalized.

5491298-X | Neuroleptic Malignant Syndrome, Pneumonia Aspiration
on May 15, 2007 Male patient from JAPAN , 81 years of age, was diagnosed with benign prostatic hyperplasia, parkinson's disease (What is parkinson's disease?) and was treated with Harnal (View Usage). Patient had the following side effects: neuroleptic malignant syndrome, pneumonia aspiration. Harnal dosage: . During the same period patient was treated with TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), ANTI PARKINSON AGENTS (View Anti-parkinson Agents Review and Anti-parkinson Agents Label ). Patient was hospitalized.

5411511-4 | Confusional State
Patient was taking Harnal (View Usage). After Harnal was administered, patient had the following side effects: confusional state on Aug 07, 2007 from JAPAN Additional patient health information: Male patient , weighting 143.3 lb, was diagnosed with benign prostatic hyperplasia, insomnia and. Harnal dosage: . During the same period patient was treated with TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), MYSLEE (View Myslee Review and Myslee Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), LAC B (View Lac B Review and Lac B Label ), NORVASC (View Norvasc Review and Norvasc Label ), KEISHIBUKURYOUGAN (View Keishibukuryougan Review and Keishibukuryougan Label ).

5403122-1 | Confusional State
Adverse event was reported on Jul 26, 2007 by a Male patient taking Harnal (View Usage) (Dosage: ) was diagnosed with benign prostatic hyperplasia and. Location: JAPAN , weighting 144.2 lb, Patient experienced the following unwanted or unexpected effects: confusional state. During the same period patient was treated with TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), MYSLEE (View Myslee Review and Myslee Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), LAC B (View Lac B Review and Lac B Label ), NORVASC (View Norvasc Review and Norvasc Label ), KEISHIBUKURYOUGAN (View Keishibukuryougan Review and Keishibukuryougan Label ).

5382316-8 | Confusional State
on Jul 03, 2007 Male patient from JAPAN , 72 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Harnal (View Usage). Patient had the following side effects: confusional state. Harnal dosage: . During the same period patient was treated with TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), SOLANAX (View Solanax Review and Solanax Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), LAC B (View Lac B Review and Lac B Label ), NORVASC (View Norvasc Review and Norvasc Label ), KEISHIBUKURYOUGAN (View Keishibukuryougan Review and Keishibukuryougan Label ).

5344421-1 | Orthostatic Hypotension
on May 29, 2007 Male patient from JAPAN , 74 years of age, weighting 149.9 lb, was diagnosed with benign prostatic hyperplasia and was treated with Harnal (View Usage). After Harnal was administered, patient had the following side effects: orthostatic hypotension. Harnal dosage: .

5330391-9 | Neuroleptic Malignant Syndrome, Pneumonia Aspiration
Patient was taking Harnal (View Usage). Patient experienced the following unwanted or unexpected effects: neuroleptic malignant syndrome, pneumonia aspiration on May 15, 2007 from JAPAN Additional patient health information: Male patient , 81 years of age, was diagnosed with benign prostatic hyperplasia, parkinson's disease (What is parkinson's disease?) and. Harnal dosage: . During the same period patient was treated with HARNAL (TAMSULOSIN) ORODISPERSABLE CR (View Harnal (tamsulosin) Orodispersable Cr Review and Harnal (tamsulosin) Orodispersable Cr Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), ANTI PARKINSON AGENTS (View Anti-parkinson Agents Review and Anti-parkinson Agents Label ). Patient was hospitalized.

5154354-1 | Cardiac Failure, Sleep Disorder
Adverse event was reported on Apr 26, 2006 by a Male patient taking Harnal (View Usage) (Dosage: ) was diagnosed with neurogenic bladder, parkinson's disease (What is parkinson's disease?), hypotension, bronchitis chronic, benign prostatic hyperplasia, constipation (What is constipation?) and. Location: JAPAN , weighting 140.9 lb, Patient had the following side effects: cardiac failure, sleep disorder (What is sleep disorder?). During the same period patient was treated with BI SIFROL TABLETS (View Bi-sifrol Tablets Review and Bi-sifrol Tablets Label ), EC DOPARL (View Ec-doparl Review and Ec-doparl Label ), DOPS (View Dops Review and Dops Label ), METLIGINE (View Metligine Review and Metligine Label ), MUCOBULIN (View Mucobulin Review and Mucobulin Label ), EVIPROSTAT (View Eviprostat Review and Eviprostat Label ), FP (View Fp Review and Fp Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ). Patient was hospitalized.

5039551-8 | Cardiac Failure
on May 30, 2006 Male patient from JAPAN , 87 years of age, was diagnosed with benign prostatic hyperplasia, dysuria and was treated with Harnal (View Usage). After Harnal was administered, patient had the following side effects: cardiac failure. Harnal dosage: . During the same period patient was treated with TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ).

5028545-4 | Cataract Nuclear, Iris Disorder
on Jan 30, 2006 Male patient from JAPAN , weighting 116.8 lb, was diagnosed with benign prostatic hyperplasia, tremor and was treated with Harnal (View Usage). Patient experienced the following unwanted or unexpected effects: cataract nuclear, iris disorder. Harnal dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), VOGLIBOSE (View Voglibose Review and Voglibose Label ), TOCOPHERYL NICOTINATE (View Tocopheryl Nicotinate Review and Tocopheryl Nicotinate Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), FLUOROMETHOLONE (View Fluorometholone Review and Fluorometholone Label ).

5018480-X | Cardiac Failure
Patient was taking Harnal (View Usage). Patient had the following side effects: cardiac failure on May 30, 2006 from JAPAN Additional patient health information: Male patient , 87 years of age, was diagnosed with benign prostatic hyperplasia and. Harnal dosage: . During the same period patient was treated with HARNAL (TAMSULOSIN) ORODISPERSABLE CR (View Harnal (tamsulosin) Orodispersable Cr Review and Harnal (tamsulosin) Orodispersable Cr Label ).

5003491-0 | Neuroleptic Malignant Syndrome
Adverse event was reported on Apr 27, 2006 by a Male patient taking Harnal (View Usage) (Dosage: ) . Location: JAPAN , 74 years of age, After Harnal was administered, patient had the following side effects: neuroleptic malignant syndrome.

4987950-2 | Neuroleptic Malignant Syndrome
on Apr 27, 2006 Male patient from JAPAN , 74 years of age, was treated with Harnal (View Usage). Patient experienced the following unwanted or unexpected effects: neuroleptic malignant syndrome. Harnal dosage: .

4984143-X | Abnormal Behaviour, Agitation, Amnesia, Delirium, Fall, Incontinence, Labile Blood Pressure, Orthostatic Hypotension, Paralysis
on Jan 16, 2006 Male patient from JAPAN , weighting 148.3 lb, was diagnosed with benign prostatic hyperplasia, dysuria, depression (What is depression?), impatience, orthostatic hypotension, myocardial infarction and was treated with Harnal (View Usage). Patient had the following side effects: abnormal behaviour, agitation, amnesia, delirium, fall (What is fall?), incontinence, labile blood pressure, orthostatic hypotension, paralysis (What is paralysis?). Harnal dosage: . During the same period patient was treated with TOLEDOMIN (View Toledomin Review and Toledomin Label ), LIMAS (View Limas Review and Limas Label ), LANDSEN (View Landsen Review and Landsen Label ), FLUVOXAMINE MALEATE (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), METLIGINE (View Metligine Review and Metligine Label ). Patient was hospitalized.

4968391-0 | Blood Alkaline Phosphatase Increased, Eosinophil Percentage Increased, Gallbladder Polyp, Gamma-glutamyltransferase Increased, Hepatobiliary Disease, Hepatomegaly
Patient was taking Harnal (View Usage). After Harnal was administered, patient had the following side effects: blood alkaline phosphatase increased, eosinophil percentage increased, gallbladder polyp, gamma-glutamyltransferase increased, hepatobiliary disease, hepatomegaly on Sep 02, 2005 from JAPAN Additional patient health information: Male patient , weighting 146.4 lb, was diagnosed with benign prostatic hyperplasia, cerebral infarction, hypertension, constipation (What is constipation?), diabetes mellitus and. Harnal dosage: . During the same period patient was treated with BUFFERIN (View Bufferin Review and Bufferin Label ), RENIVEZE (View Reniveze Review and Reniveze Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ), CETILO (RHUBARB/SENNA) (View Cetilo (rhubarb/senna) Review and Cetilo (rhubarb/senna) Label ), INSULIN INJECTION, BIPHASIC (View Insulin Injection, Biphasic Review and Insulin Injection, Biphasic Label ). Patient was hospitalized.

4941854-X | Delirium, Incontinence, Labile Blood Pressure, Mobility Decreased, Subdural Hygroma, Syncope
Adverse event was reported on Jan 19, 2006 by a Male patient taking Harnal (View Usage) (Dosage: ) was diagnosed with dysuria, orthostatic hypotension and. Location: JAPAN , 75 years of age, Patient experienced the following unwanted or unexpected effects: delirium, incontinence, labile blood pressure, mobility decreased, subdural hygroma, syncope. During the same period patient was treated with ETILEFRINE HYDROCHLORIDE (View Etilefrine Hydrochloride Review and Etilefrine Hydrochloride Label ).

4932782-4 | Anaemia
on Jan 24, 2006 Male patient from JAPAN , weighting 104.7 lb, was diagnosed with benign prostatic hyperplasia, right ventricular failure, bronchopulmonary aspergillosis, gastrointestinal motility disorder, asthma (What is asthma?), reflux oesophagitis and was treated with Harnal (View Usage). Patient had the following side effects: anaemia. Harnal dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ITRIZOLE (View Itrizole Review and Itrizole Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), GASCON (View Gascon Review and Gascon Label ), UNIPHYL (View Uniphyl Review and Uniphyl Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ). Patient was hospitalized.

4931762-2 | Anaemia
on Jan 24, 2006 Male patient from JAPAN , weighting 104.7 lb, was diagnosed with benign prostatic hyperplasia, right ventricular failure, bronchopulmonary aspergillosis, gastrointestinal motility disorder, asthma (What is asthma?), reflux oesophagitis and was treated with Harnal (View Usage). After Harnal was administered, patient had the following side effects: anaemia. Harnal dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ITRIZOLE (View Itrizole Review and Itrizole Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), GASCON (View Gascon Review and Gascon Label ), UNIPHYL (View Uniphyl Review and Uniphyl Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ). Patient was hospitalized.

4929479-3 | Liver Disorder, Renal Disorder
Patient was taking Harnal (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder, renal disorder on Feb 14, 2006 from JAPAN Additional patient health information: Male patient , 84 years of age, was diagnosed with benign prostatic hyperplasia and. Harnal dosage: . During the same period patient was treated with DANTRIUM (View Dantrium Review and Dantrium Label ), ACECOL (View Acecol Review and Acecol Label ), SG (ISOPROPYLANTIPYRINE) (View Sg (isopropylantipyrine) Review and Sg (isopropylantipyrine) Label ). Patient was hospitalized.

4924554-1 | Face Oedema, Glossodynia, Hyperthermia, Upper Respiratory Tract Inflammation
Adverse event was reported on Feb 08, 2006 by a Male patient taking Harnal (View Usage) (Dosage: ) was diagnosed with benign prostatic hyperplasia and. Location: JAPAN , weighting 154.3 lb, Patient had the following side effects: face oedema, glossodynia, hyperthermia, upper respiratory tract inflammation. During the same period patient was treated with KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), BLOPRESS (View Blopress Review and Blopress Label ), PROTECADIN (View Protecadin Review and Protecadin Label ), LEXIN (View Lexin Review and Lexin Label ). Patient was hospitalized.

4924552-8 | Anaemia
on Jan 24, 2006 Male patient from JAPAN , weighting 104.7 lb, was diagnosed with benign prostatic hyperplasia and was treated with Harnal (View Usage). After Harnal was administered, patient had the following side effects: anaemia. Harnal dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ITRIZOLE (View Itrizole Review and Itrizole Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), GASCON (View Gascon Review and Gascon Label ), UNIPHYL (View Uniphyl Review and Uniphyl Label ), TAKEPRON (View Takepron Review and Takepron Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ). Patient was hospitalized.

4923386-8 | Cataract Nuclear, Iris Disorder, Procedural Complication
on Jan 30, 2006 Male patient from JAPAN , weighting 116.8 lb, was diagnosed with benign prostatic hyperplasia, tremor and was treated with Harnal (View Usage). Patient experienced the following unwanted or unexpected effects: cataract nuclear, iris disorder, procedural complication. Harnal dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), VOGLIBOSE (View Voglibose Review and Voglibose Label ), TOCOPHERYL NICOTINATE (View Tocopheryl Nicotinate Review and Tocopheryl Nicotinate Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), FLUOROMETHOLONE (View Fluorometholone Review and Fluorometholone Label ).

4920080-4 | Liver Disorder, Renal Disorder
Patient was taking Harnal (View Usage). Patient had the following side effects: liver disorder, renal disorder on Feb 14, 2006 from JAPAN Additional patient health information: Male patient , 84 years of age, was diagnosed with benign prostatic hyperplasia and. Harnal dosage: . During the same period patient was treated with DANTRIUM (25 Mg, Prn) (View Dantrium Review and Dantrium Label ), ACECOL (View Acecol Review and Acecol Label ), SG (ISOPROPYLANTIPYRINE) (View Sg (isopropylantipyrine) Review and Sg (isopropylantipyrine) Label ). Patient was hospitalized.

4913590-7 | Dementia
Adverse event was reported on Feb 10, 2006 by a Male patient taking Harnal (View Usage) (Dosage: ) was diagnosed with benign prostatic hyperplasia and. Location: JAPAN , 76 years of age, After Harnal was administered, patient had the following side effects: dementia (What is dementia?). During the same period patient was treated with TANATRIL (View Tanatril Review and Tanatril Label ).

4907841-2 | Blood Creatinine Increased, Blood Urea Increased, Blood Uric Acid Increased
on Dec 13, 2005 Male patient from JAPAN , 83 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Harnal (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood urea increased, blood uric acid increased. Harnal dosage: . During the same period patient was treated with TOCOPHERYL NICOTINATE (View Tocopheryl Nicotinate Review and Tocopheryl Nicotinate Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), BUFFERIN (View Bufferin Review and Bufferin Label ), EFONIDIPINE HYDROCHLORIDE (View Efonidipine Hydrochloride Review and Efonidipine Hydrochloride Label ).

4895469-2 | Delirium, Labile Blood Pressure, Subdural Hygroma, Syncope
on Jan 19, 2006 Male patient from JAPAN , 75 years of age, was diagnosed with dysuria, orthostatic hypotension and was treated with Harnal (View Usage). Patient had the following side effects: delirium, labile blood pressure, subdural hygroma, syncope. Harnal dosage: . During the same period patient was treated with ETILEFRINE HYDROCHLORIDE (View Etilefrine Hydrochloride Review and Etilefrine Hydrochloride Label ).

4891829-4 | Delirium, Depression, Incontinence, Labile Blood Pressure, Skin Laceration, Subdural Hygroma, Syncope
Patient was taking Harnal (View Usage). After Harnal was administered, patient had the following side effects: delirium, depression (What is depression?), incontinence, labile blood pressure, skin laceration, subdural hygroma, syncope on Jan 19, 2006 from JAPAN Additional patient health information: Male patient , 75 years of age, was diagnosed with dysuria, orthostatic hypotension and. Harnal dosage: . During the same period patient was treated with ETILEFRINE HYDROCHLORIDE (View Etilefrine Hydrochloride Review and Etilefrine Hydrochloride Label ).

4883909-4 | Retinal Detachment
Adverse event was reported on Aug 26, 2005 by a Male patient taking Harnal (View Usage) (Dosage: ) was diagnosed with benign prostatic hyperplasia and. Location: JAPAN , 66 years of age, Patient experienced the following unwanted or unexpected effects: retinal detachment. During the same period patient was treated with CERNILTON (View Cernilton Review and Cernilton Label ).

4856263-1 | Blood Creatinine Increased, Blood Urea Increased, Blood Uric Acid Increased
on Dec 13, 2005 Male patient from JAPAN , 83 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Harnal (View Usage). Patient had the following side effects: blood creatinine increased, blood urea increased, blood uric acid increased. Harnal dosage: . During the same period patient was treated with TOCOPHERYL NICOTINATE (View Tocopheryl Nicotinate Review and Tocopheryl Nicotinate Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), BUFFERIN (View Bufferin Review and Bufferin Label ), EFONIDIPINE HYDROCHLORIDE (View Efonidipine Hydrochloride Review and Efonidipine Hydrochloride Label ).

4842669-3 | Interstitial Lung Disease
on Nov 18, 2005 Male patient from JAPAN , 82 years of age, was treated with Harnal (View Usage). After Harnal was administered, patient had the following side effects: interstitial lung disease. Harnal dosage: .

4837378-0 | Interstitial Lung Disease
Patient was taking Harnal (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease on Nov 18, 2005 from JAPAN Additional patient health information: Male patient , 82 years of age, . Harnal dosage: .

4837377-9 | Dermatitis Exfoliative
Adverse event was reported on Nov 18, 2005 by a Male patient taking Harnal (View Usage) (Dosage: ) was diagnosed with benign prostatic hyperplasia and. Location: JAPAN , 83 years of age, Patient had the following side effects: dermatitis exfoliative. During the same period patient was treated with ACECOL (View Acecol Review and Acecol Label ), MEILAX (View Meilax Review and Meilax Label ).

4831032-7 | Depressed Level Of Consciousness, Flushing, Lymphocyte Stimulation Test Positive
on Nov 14, 2005 Male patient from , 69 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Harnal (View Usage). After Harnal was administered, patient had the following side effects: depressed level of consciousness, flushing, lymphocyte stimulation test positive. Harnal dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), OXPRENOLOL (View Oxprenolol Review and Oxprenolol Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), CLOSTRIDUM BUTYRICUM (View Clostridum Butyricum Review and Clostridum Butyricum Label ).

4829823-1 | Depressed Level Of Consciousness, Flushing
on Nov 14, 2005 Male patient from , 69 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Harnal (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, flushing. Harnal dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), OXPRENOLOL (View Oxprenolol Review and Oxprenolol Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), CLOSTRIDUM BUTYRICUM (View Clostridum Butyricum Review and Clostridum Butyricum Label ).

4820278-X | Amaurosis Fugax, Orthostatic Hypotension
Patient was taking Harnal (View Usage). Patient had the following side effects: amaurosis fugax, orthostatic hypotension on Oct 21, 2005 from JAPAN Additional patient health information: Male patient , 74 years of age, was diagnosed with benign prostatic hyperplasia and. Harnal dosage: . Patient was hospitalized.